Erwin P. Bottinger MD

Erwin Bottinger is the Co-Director of the Hasso Plattner Institute for Digital Health at Mount Sinai (HPI·MS) in New York City, USA, and Head of the Digital Health Center at the Hasso Plattner Institute (HPI) in Potsdam, Germany. He holds dual academic appointments as Professor of Medicine and Systems Pharmacology and Therapeutics at the Icahn School of Medicine at Mount Sinai, New York City, USA, and Chaired Professor for Digital Health - Personalized Medicine at the joint Digital Engineering Faculty of the HPI and University Potsdam. From November 2015 to July 2017 Erwin Bottinger was the CEO of the Berlin Institute of Health (BIH) where he played a key role in shaping its forward-looking strategy for 'Personalized Medicine - Advanced Therapies. From 2007 to 2015, he served as Founding Director of the Charles Bronfman Institute for Personalized Medicine at the Icahn School of Medicine at Mount Sinai and the principal architect of the Institute’s BioMe™ Biobank. Erwin Bottinger is a pioneer in groundbreaking implementations of personalized medicine and digital health in clinical practice.